Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder

Madsen, Trine; Buttenschøn, Henriette N; Uher, Rudolf; Behrendt-Møller, Ida; Perroud, Nader Ali; Maier, Wolfgang; Hauser, Joanna; Dernovsek, Mojca Zvezdana; Henigsberg, Neven; Souery, Daniel; Rietschel, Marcella; McGuffin, Peter; Aitchison, Katherine J; Mors, Ole; Köhler-Forsberg, Ole

doi:10.4088/JCP.18m12575

Scientific article

English

Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder

ContributorsMadsen, Trine; Buttenschøn, Henriette N; Uher, Rudolf; Behrendt-Møller, Ida; Perroud, Nader Ali

; Maier, Wolfgang; Hauser, Joanna; Dernovsek, Mojca Zvezdana; Henigsberg, Neven; Souery, Daniel; Rietschel, Marcella; McGuffin, Peter; Aitchison, Katherine J; Mors, Ole; Köhler-Forsberg, Ole

Published inJournal of Clinical Psychiatry, vol. 80, no. 4, p. e1-e7

Publication date2019

Abstract

Suicidal ideation is a frequent and difficult-to-treat clinical challenge among patients with major depressive disorder (MDD). However, little is known regarding the differential development during antidepressant treatment and whether some patients may suffer from persistent suicidal ideation.

Keywords

Adult
Antidepressive Agents/administration & dosage/adverse effects
Citalopram/administration & dosage/adverse effects
Depressive Disorder, Major/diagnosis/drug therapy/psychology
Europe
Female
Humans
Male
Nortriptyline/administration & dosage/adverse effects
Suicidal Ideation
Suicide/prevention & control/psychology
Treatment Outcome

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de psychiatrie

Research groups

Thérapeutiques des Troubles de l'Humeur et Anxieux (689)

Citation (ISO format)

MADSEN, Trine et al. Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder. In: Journal of Clinical Psychiatry, 2019, vol. 80, n° 4, p. e1–e7. doi: 10.4088/JCP.18m12575

Article (Published version)

Identifiers

PID : unige:144995
DOI : 10.4088/JCP.18m12575
PMID : 31318184

Additional URL for this publicationhttps://www.psychiatrist.com/JCP/article/Pages/trajectories-of-suicidal-ideation-in-mdd.aspx

Journal ISSN0160-6689

374views

0downloads

Creation29/10/2020 16:22:00

First validation29/10/2020 16:22:00

Update time15/03/2023 23:24:29

Status update15/03/2023 23:24:28

Last indexation31/10/2024 20:27:20

Archive ouverte UNIGE

Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder

Suicidal ideation is a frequent and difficult-to-treat clinical challenge among patients with major depressive disorder (MDD). However, little is known regarding the differential development during antidepressant treatment and whether some patients may suffer from persistent suicidal ideation.

Technical informations